Unknown

Dataset Information

0

Design and Synthesis of Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors.


ABSTRACT: The molecular chaperone Hsp90, essential in all eukaryotes, plays a multifaceted role in promoting survival, virulence, and drug resistance across diverse pathogenic fungal species. The chaperone is also critically important, however, to the pathogen's human host, preventing the use of known clinical Hsp90 inhibitors in antifungal applications due to concomitant host toxicity issues. With the goal of developing Hsp90 inhibitors with acceptable therapeutic indices for the treatment of invasive fungal infections, we initiated a program to design and synthesize potent inhibitors with selective activity against fungal Hsp90 isoforms over their human counterparts. Building on our previously reported derivatization of resorcylate natural products to produce fungal-selective compounds, we have developed a series of synthetic aminopyrazole-substituted resorcylate amides with broad, potent, and fungal-selective Hsp90 inhibitory activity. Herein we describe the synthesis of this series, as well as biochemical structure-activity relationships driving selectivity for the Hsp90 isoforms expressed by Cryptococcus neoformans and Candida albicans, two pathogenic fungi of major clinical importance.

SUBMITTER: Huang DS 

PROVIDER: S-EPMC7069776 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Design and Synthesis of Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors.

Huang David S DS   LeBlanc Emmanuelle V EV   Shekhar-Guturja Tanvi T   Robbins Nicole N   Krysan Damian J DJ   Pizarro Juan J   Whitesell Luke L   Cowen Leah E LE   Brown Lauren E LE  

Journal of medicinal chemistry 20190926 5


The molecular chaperone Hsp90, essential in all eukaryotes, plays a multifaceted role in promoting survival, virulence, and drug resistance across diverse pathogenic fungal species. The chaperone is also critically important, however, to the pathogen's human host, preventing the use of known clinical Hsp90 inhibitors in antifungal applications due to concomitant host toxicity issues. With the goal of developing Hsp90 inhibitors with acceptable therapeutic indices for the treatment of invasive fu  ...[more]

Similar Datasets

| S-EPMC8493596 | biostudies-literature
| S-EPMC4266361 | biostudies-literature
| S-EPMC2697668 | biostudies-literature
| S-EPMC5789427 | biostudies-other
| S-EPMC4025795 | biostudies-other
| S-EPMC4406240 | biostudies-literature
| S-EPMC5214847 | biostudies-literature
| S-EPMC2933939 | biostudies-literature
| S-EPMC8634768 | biostudies-literature
| S-EPMC6295223 | biostudies-literature